[1] Nesterova AP, Klimov EA, Zharkova M et al. Chapter 2 - Infectious diseases. 2020:35-94. doi:10.1016/B978-0-12-817086-1.00002-6.
[2] Zhang Y, Zhang Y, Dong B, et al. Safety Assessment of Concurrent Vaccination with the HPV Vaccine and the COVID-19 Vaccine in Fujian Province, China: A Retrospective Study. Vaccines (Basel). 2024;12(6):673. Published 2024 Jun 18. doi:10.3390/vaccines12060673
[3] Gong L, Ji HH, Tang XW, Pan LY, Chen X, Jia YT. Human papillomavirus vaccine-associated premature ovarian insufficiency and related adverse events: data mining of Vaccine Adverse Event Reporting System. Sci Rep. 2020;10(1):10762. Published 2020 Jul 1. doi:10.1038/s41598-020-67668-1
[4] Gardasil 9 [prescribing information]. Whitehouse Station, NJ: Merck & Co., Inc.; 2022.
[5] Male V. Menstruation and covid-19 vaccination. BMJ. 2022;376:o142. Published 2022 Jan 26. doi:10.1136/bmj.o142
[6] Male V. Menstrual changes after covid-19 vaccination. BMJ. 2021;374:n2211. Published 2021 Sep 15. doi:10.1136/bmj.n2211
[7] Wise LD, Wolf JJ, Kaplanski CV, Pauley CJ, Ledwith BJ. Lack of effects on fertility and developmental toxicity of a quadrivalent HPV vaccine in Sprague-Dawley rats. Birth Defects Res B Dev Reprod Toxicol. 2008;83(6):561-572. doi:10.1002/bdrb.20174
[8] McInerney KA, Hatch EE, Wesselink AK, et al. The Effect of Vaccination Against Human Papillomavirus on Fecundability. Paediatr Perinat Epidemiol. 2017;31(6):531-536. doi:10.1111/ppe.12408
[9] Torella M, Marrapodi MM, Ronsini C, et al. Risk of Premature Ovarian Insufficiency after Human Papilloma Virus Vaccination: A PRISMA Systematic Review and Meta-Analysis of Current Evidence. Vaccines (Basel). 2023;11(1):140. Published 2023 Jan 9. doi:10.3390/vaccines11010140
[10] Suzuki S, Hosono A. No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya study. Papillomavirus Res. 2018;5:96-103. doi:10.1016/j.pvr.2018.02.002
[11] World Health Organization. Global Advisory Committee on Vaccine Safety. Safety of HPV vaccines. July 2017. https://www.who.int/groups/global-advisory-committee-on-vaccine-safety/topics/human-papillomavirus-vaccines/safety